发明授权
US07229636B1 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
有权
用于鼻内给药的氰钴胺素低粘度含水制剂
- 专利标题: Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
- 专利标题(中): 用于鼻内给药的氰钴胺素低粘度含水制剂
-
申请号: US10787385申请日: 2004-02-26
-
公开(公告)号: US07229636B1公开(公告)日: 2007-06-12
- 发明人: Steven C. Quay , Peter C. Aprile , Zenaida O. Go , Anthony P. Sileno
- 申请人: Steven C. Quay , Peter C. Aprile , Zenaida O. Go , Anthony P. Sileno
- 申请人地址: US WA Bothell
- 专利权人: Nastech Pharmaceutical Company Inc.
- 当前专利权人: Nastech Pharmaceutical Company Inc.
- 当前专利权人地址: US WA Bothell
- 代理商 Peter J. Knudsen
- 主分类号: A61F13/00
- IPC分类号: A61F13/00
摘要:
A stable pharmaceutical mercury-free aqueous solution of cyanocobalamin comprised of cyanocobalamin and water wherein said solution of cyanocobalamin is suitable for intranasal administration, has a viscosity less than about 1000 cPs, and wherein said solution of cyanocobalamin has a bioavailability of cyanocobalamin when administered intranasally of at least about 7% relative to an intramuscular injection of cyanocobalamin with the proviso that the solution is essentially free of mercury and mercury-containing compounds. The present invention is also directed towards a method for elevating the vitamin B12 levels in the cerebral spinal fluid (CSF) comprising administering intranasally a sufficient amount of a mercury-free cyanocobalamin solution so as to increase the average ratio of vitamin B12 in the CSF to that in the blood serum (B12 CSF/B12 Serum×100) to at least about 1.1 comprising intranasally administering an aqueous solution of a cyanocobalamin, wherein said solution of cyanocobalamin has a bioavailability of at least 7% relative to an intramuscular injection of a cyanocobalamin.
信息查询